Navigation Links
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
Date:5/8/2009

ates of the H1N1 virus were tested for sensitivity to peramivir and all ten isolates were susceptible to peramivir.

Intramuscular Peramivir Phase 2 Study Results for Seasonal Influenza

BioCryst also announced preliminary results from its Phase 2 study of intramuscular (i.m.) peramivir for the treatment of seasonal influenza. While the study demonstrated a numerical trend in its primary endpoint of improvement in the median time to alleviation of symptoms (TTAS) in subjects with confirmed, acute, uncomplicated influenza infection versus placebo, the difference between the two study groups was not statistically significant.

The median TTAS was 91.1 hours for those receiving a single 600 mg injection of i.m. peramivir, compared to 106.1 hours observed in those patients receiving placebo (p=0.22). The trial indicated that peramivir was generally safe and well tolerated with a similar adverse event profile noted in the peramivir and placebo treatment groups.

"The efficacy of intravenous peramivir demonstrated in a prior study conducted by Shionogi & Company Ltd. indicates its potential as a treatment for acute uncomplicated influenza," commented Dr. William P. Sheridan, Chief Medical Officer of BioCryst. "Based on the clinical evidence of activity, safety and tolerability of peramivir, we are currently in discussions with HHS-BARDA and the U.S. Food and Drug Administration (FDA) regarding further development of i.v. peramivir as a treatment for influenza."

This Phase 2 study (BCX1812-212) was a randomized, double-blind, placebo-controlled trial conducted in influenza seasons in the Southern Hemisphere (Australia, New Zealand and South Africa) in 2008 and the Northern Hemisphere (United States) in 2008 - 2009. It enrolled 405 subjects 18 years of age or older with acute uncomplicated influenza confirmed by positive rapid antigen test, whose symptom duration was 36 hours
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
2. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
3. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
4. BioCryst Updates Peramivir Clinical Development Plan
5. BioCryst Provides Forodesine HCl Update
6. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
7. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
8. USAID Provides $5M in Emergency Support as Swine Flu Spreads
9. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
10. Strativa Pharmaceuticals Provides Product Pipeline Update
11. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  Synapse Biomedical Inc. ( www.synapsebiomedical.com ) announced ... post-approval study of its NeuRx DPS® System for ... the FDA enrollment requirement was implanted over a ... NeuRx DPS®, which is the only medical device ... is a humanitarian device that obtained approval at ...
(Date:9/30/2014)... , Sept. 30, 2014 EXECUTIVE SUMMARY ... Industry Outlook to 2017 - Increasing Demand from ... analysis of the industry past, present and future ... Canada market with outlook to ... dietary supplements. Additionally the sub-segments of the industry, ...
(Date:9/30/2014)... DURHAM, N.C. , Sept. 30, 2014 /PRNewswire/ ... that Viztek LLC (Viztek), a leading provider of ... licensed HeartIT,s zero footprint patent portfolio. The licensed ... to provide access to diagnostic-quality medical images in ... part of the agreement, Viztek and its Subsidiaries ...
Breaking Medicine Technology:Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 2North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 3
... 2011 Varian Medical Systems (NYSE: ... order from U.S. Customs and Border Protection (CBP) for multiple ... represents the company,s largest single order for Varian,s IntellX gantry ... border, scanning vehicles for both border security and manifest verification ...
... PITTSBURGH, Jan. 27, 2011 Mylan Inc. (Nasdaq: ... subsidiary Matrix Laboratories Limited has signed an agreement ... manufacture, market and distribute a generic version of ... pending its regulatory approval for the treatment of ...
Cached Medicine Technology:Varian Medical Systems' Security and Inspection Products Group Receives Largest Single Order for IntellX Systems 2Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment 2
(Date:9/30/2014)... HealthDay Reporter , MONDAY, Sept. ... broad-spectrum antibiotics before the age of 2 may face ... new research suggests. Broad-spectrum antibiotics target a larger ... study. "It is a reason to think about ... picking," said lead researcher Dr. Charles Bailey, attending physician ...
(Date:9/30/2014)... Edward D. Buckingham, M.D., owner of ... approved to be a director of a fellowship for ... (AAFPRS) fellowship program. The announcement came last week from ... The Educational and Research Foundation for the AAFPRS fellowship ... the finest postgraduate program in the world for the ...
(Date:9/30/2014)... Gummy teeth treatment expert, Dr. ... dark gums. Dark gums are usually considered a cosmetic ... about their smiles. Dr. Farnoosh has pioneered a procedure ... of the few dental professionals nationwide offering black ... leaders, high-ranking officials and patients from all over the ...
(Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. ... supplements won,t prevent the return of a common type of ... In fact, 64.1 percent of those taking fish oil for ... over the course of 16 months, compared to 63.2 ... did not reduce the twin ills of inflammation or oxidative ...
(Date:9/30/2014)... 30, 2014 Lea Blackwell, M.D., a ... cancer patients a new, more practical and comfortable option ... undergo mastectomies, biopsies and lumpectomy surgeries use special bras ... after seeing her patients describe the bra as scratchy, ... a new bra in her spare time. , ...
Breaking Medicine News(10 mins):Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 2Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 3Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:Gummy Smile Dentist, Dr. Alex Farnoosh, is Now Offering Gum Depigmentation for Dark Gums 2Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 2Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 3Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3
... many as 10% of people of Asian descent, operations ... mathematical models that verified the cost effectiveness of hepatitis ... vaccinate millions of Asian and Pacific Islander adults in ... to a paper in a journal of the Institute ...
... (HealthDay News) -- In the days after they start ... bupropion or venlafaxine, nursing home residents are at significantly ... Researchers found the increased risk for falls also ... their current prescription. "Our results identify the days ...
... increasing globally. Requiring two doctors to agree that a ... baby, rather than just needing one opinion, providing internal ... and seeking support from local opinion leaders may reduce ... relaxation classes for women with a fear or anxiety ...
... spoils of war for returning veterans may include addictions, ... witnessed. Now a University of Houston joint study ... Development service looks to address these issues through the ... College of Social Work (GCSW) joins Baylor College of ...
... News) -- Depression rates are higher in richer countries ... who compared socioeconomic conditions with depression. About 121 ... quality of life by affecting their ability to ... suicide and causes 850,000 deaths every year. Detailed ...
... 26 (HealthDay News) -- A person,s brain works hard to ... people,s shoes, no matter how different they may be, a ... California found people automatically attempt to empathize -- even with ... people must use two separate regions of their brain. ...
Cached Medicine News:Health News:INFORMS study: OR models of hepatitis B prove decisive in treating millions in US, China 2Health News:INFORMS study: OR models of hepatitis B prove decisive in treating millions in US, China 3Health News:Certain Antidepressants Linked to Falls in Nursing Homes 2Health News:Local efforts can stem the increasing unnecessary cesarean sections 2Health News:Returning vets' alcohol abuse addressed in virtual reality study 2Health News:Depression Higher in Wealthier Nations 2Health News:Human Brains Wired to Empathize, Study Finds 2
The WatchMate ID model displays multiple alarms locally with resident ID numbers and this information, along with residents names, can be displayed at a central station. Alarms may be cleared locall...
... Radianse indoor positioning ... measure of where and ... patients flow through care ... data provides intelligence that ...
... supports patient safety by providing patient ... patients are in the right place ... the exact patient location when a ... Measure patient flow times to identify ...
... VACUETTE Blood Collection Needles are preominantly used ... for single-use. The colour of the needle ... individual needle gauges. For example, yellow symbolises ... green 21 G (0.80 mm) and black ...
Medicine Products: